Theseus Pharmaceuticals Cash Flow Statement

Financials in millions MYR. Fiscal year is January - December.

Millions MYR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Net Income	-	10.81	26.42	45.46	52.95	50.8	Upgrade
Depreciation & Amortization	-	11.98	14.52	21.84	27.64	40.74	Upgrade
Loss (Gain) From Sale of Assets	-	-0.06	-1.98	-0.3	-0.48	-1.27	Upgrade
Asset Writedown & Restructuring Costs	-	-	0.98	-	0.45	0.72	Upgrade
Loss (Gain) on Equity Investments	-	-0.25	0.13	0.28	-0.18	-0.05	Upgrade
Stock-Based Compensation	-	-	0.5	0.86	1.06	-	Upgrade
Provision & Write-off of Bad Debts	-	-	-	-	-	-0.44	Upgrade
Other Operating Activities	-	-4.69	-4.07	-1.93	-1.13	-3.21	Upgrade
Change in Accounts Receivable	-	-61.67	8.57	3.63	10.9	-1.88	Upgrade
Change in Inventory	-	-2.5	2.93	-0.96	-2.54	2.65	Upgrade
Change in Accounts Payable	-	-0.83	-2.49	-7.06	-0.31	-1.78	Upgrade
Operating Cash Flow	-	-47.22	45.5	61.83	88.36	86.28	Upgrade
Operating Cash Flow Growth	-	-	-26.41%	-30.02%	2.41%	-22.99%	Upgrade
Capital Expenditures	-	-7.87	-24.04	-14.33	-12.83	-17.56	Upgrade
Sale of Property, Plant & Equipment	-	0.34	1.98	0.44	3.07	2.23	Upgrade
Sale (Purchase) of Real Estate	-	-	-0.01	-0.02	-	-	Upgrade
Investment in Securities	-	-0.02	-0.02	2.32	0.9	-0.67	Upgrade
Other Investing Activities	-	4.86	4.65	2.28	1.59	1.81	Upgrade
Investing Cash Flow	-	-2.7	-17.44	-9.31	-7.27	-14.19	Upgrade
Long-Term Debt Repaid	-	-	-	-	-	-4.13	Upgrade
Total Debt Repaid	-	-	-	-	-	-4.13	Upgrade
Net Debt Issued (Repaid)	-	-	-	-	-	-4.13	Upgrade
Issuance of Common Stock	-	3.09	3.42	-	-	-	Upgrade
Common Dividends Paid	-	-6.75	-16.74	-46.86	-50.21	-50.21	Upgrade
Financing Cash Flow	-	-10.42	-20.03	-46.86	-50.21	-54.34	Upgrade
Foreign Exchange Rate Adjustments	-	-0.45	0.59	0.74	0.56	-0.33	Upgrade
Miscellaneous Cash Flow Adjustments	-	0	-	-	-	-	Upgrade
Net Cash Flow	-	-60.78	8.62	6.4	31.43	17.43	Upgrade
Free Cash Flow	-	-55.09	21.46	47.5	75.53	68.72	Upgrade
Free Cash Flow Growth	-	-	-54.82%	-37.10%	9.90%	-27.76%	Upgrade
Free Cash Flow Margin	-	-49.81%	16.28%	26.38%	36.66%	30.20%	Upgrade
Free Cash Flow Per Share	-	-0.08	0.03	0.07	0.11	0.10	Upgrade
Cash Income Tax Paid	-	6.36	6.9	5.46	1.67	0.94	Upgrade
Levered Free Cash Flow	-	-53.5	21.38	34.42	55.32	55.71	Upgrade
Unlevered Free Cash Flow	-	-53.5	21.38	34.42	55.32	55.71	Upgrade
Change in Net Working Capital	52.57	65.21	-13.27	4.56	-6.19	-2	Upgrade

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.